Metabolic barriers to immunotherapy in renal cell carcinoma.

被引：2
|
作者：
Beckermann, Katy
Siska, Peter
Mason, Frank
Rathmell, Kimryn
Rathmell, Jeffrey C.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Vanderbilt Univ, Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11560
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Feasibility study of gene gun mediated immunotherapy for renal cell carcinoma.
    Seigne, J
    Turner, J
    Diaz, J
    Hackney, J
    Pow-Sang, J
    Helal, M
    Lockhart, J
    Yu, H
    JOURNAL OF UROLOGY, 1999, 162 (04): : 1259 - 1263
  • [2] Immunotherapy in metastatic renal cell carcinoma. With special regard to treatment of the elderly
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2003, 42 (11): : 1450 - 1452
  • [3] Treatment of metastatic renal cell carcinoma. Immunotherapy versus surgical removal
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2000, 39 (04): : 356 - 361
  • [4] Comorbidity burden and effectiveness of immunotherapy in patients with metastatic renal cell carcinoma.
    Yekeduz, Emre
    Zarba, Martin
    Saad, Eddy
    Wells, Connor
    Machaalani, Marc
    Chehade, Razane El Hajj
    Eid, Marc
    Labaki, Chris
    Nawfal, Rashad
    Saliby, Renee Maria
    Semaan, Karl
    Steiner, Clara
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [5] Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
    Di Nunno, Vincenzo
    Gatto, Lidia
    Fragomeno, Benedetta
    Cubelli, Marta
    Nobili, Elisabetta
    Romano, Ida
    Santoni, Matteo
    Pisconti, Salvatore
    Montironi, Rodolfo
    Massari, Francesco
    FUTURE ONCOLOGY, 2018, 14 (29) : 2997 - 2999
  • [6] Data to decisions: The impact of online education on immunotherapy in advanced renal cell carcinoma.
    Parikh, Kinjal
    Lucero, Katie
    Warren, Charlotte
    Van Laar, Emily Sherene
    Carothers, Ann
    Kadkhoda, Haleh
    Rini, Brian, I
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Advanced renal cell carcinoma.
    Redman B.G.
    Chang A.E.
    Current Treatment Options in Oncology, 2000, 1 (5) : 417 - 422
  • [8] Immunotherapy in metastasized renal cell carcinoma. Current status and indications for clinical application
    Heuer, R.
    Eichelberg, C.
    Zacharias, M.
    Heinzer, H.
    ONKOLOGE, 2008, 14 (10): : 1040 - +
  • [9] Genomic and metabolic characterization of succinate dehydrogenase B deficient renal cell carcinoma.
    Lee, Chung-Han
    Wel, Elizabeth
    Lee, William
    Chen, Yingbei
    Mano, Roy
    Hakimi, A. Ari
    Dong, Yiyu
    Redzematovic, Almedina
    Cross, Justin R.
    Tickoo, Satish
    Srinivasan, Ramaprasad
    Oschwald, Dayna
    Reuter, Victor E.
    Dunphy, Mark
    Cheng, Emily
    Motzer, Robert J.
    Linehan, W. Marston
    Hsieh, James
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Association between tumor burden and response to immunotherapy in patients with metastatic renal cell carcinoma.
    Yasin, Hesham Abdallah
    Chen, Yu-Wei
    Tucker, Matthew D.
    Beckermann, Katy
    Schaffer, Kerry
    Davis, Nancy B.
    McAlister, Renee
    Wallace, Deborah
    Kaiser, Elizabeth
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345